NCT00431093View on ClinicalTrials.gov

Trial to Compare the Effects of Tibolone (Livial®) and Continuous Combined Low-Dose Estradiol/Noresterone (Activelle®)

PHASE4CompletedINTERVENTIONAL
Enrollment

570

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
Menopause
Interventions
DRUG

tibolone

uncoded tablets, at a dose of 2.5 mg per tablet; Subjects were to take 1 Livialâ tablet and 1 -matched Activelleâ placebo tablet, orally, once a day (preferably at the same time).

DRUG

low-dose estradiol/noresterone

"Activelleâ, estradiol (E2) 1 mg and norethisterone acetate (NETA) 0.5 mg per tablet, was supplied as uncoded tablets.~Subjects were to take 1 Activelleâ tablet and 1 Livialâ-matched placebo tablet, orally, once a day (preferably at the same time)."

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00431093 - Trial to Compare the Effects of Tibolone (Livial®) and Continuous Combined Low-Dose Estradiol/Noresterone (Activelle®) | Biotech Hunter | Biotech Hunter